Evaluation of clarithromycin resistance and cagA and vacA genotyping of Helicobacter pylori strains from the West of Ireland using line probe assays

被引:18
作者
Ryan, KA
van Doorn, LJ
Moran, AP
Glennon, M
Smith, T
Maher, M [1 ]
机构
[1] Natl Univ Ireland Univ Coll Galway, Natl Diagnost Ctr, DNA Diagnost Lab, BioRes Ireland, Galway, Ireland
[2] Natl Univ Ireland Univ Coll Galway, Dept Microbiol, Galway, Ireland
[3] Delft Diagnost Lab, Delft, Netherlands
关键词
D O I
10.1128/JCM.39.5.1978-1980.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The prevalence of clarithromycin resistance-associated mutations, the cytotoxin-associated gene (cagA), and the various vacuolating cytotoxin (vacA) genotypes was determined in 50 gastric biopsy specimens from Helicobacter pylori-infected patients, using line probe assays, The clarithromycin resistance-associated mutation A2143G was detected in H. pylori strains from 26% of the specimens, which suggested that the high I ate of H, pylori treatment failure in Ireland may be partly attributable to the presence of these mutations,;UI strains examined carried the vacA s1 genotype. and 76% were cagA positive, Of these 50 specimens, 13 (26%) carried H. pylori strains with vacA midregion genotype mi, 29 (58%) carried strains that were m2, 1 (2%) was infected by a strain that was positive for both mi and m2, and 7 (14%) carried strains that could not be typed.
引用
收藏
页码:1978 / 1980
页数:3
相关论文
共 21 条
[1]   Antibiotic resistance problems with Helicobacter pylori [J].
Alarcón, T ;
Domingo, D ;
López-Brea, M .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1999, 12 (01) :19-26
[2]   MOSAICISM IN VACUOLATING CYTOTOXIN ALLELES OF HELICOBACTER-PYLORI - ASSOCIATION OF SPECIFIC VACA TYPES WITH CYTOTOXIN PRODUCTION AND PEPTIC-ULCERATION [J].
ATHERTON, JC ;
CAO, P ;
PEEK, RM ;
TUMMURU, MKR ;
BLASER, MJ ;
COVER, TL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (30) :17771-17777
[3]  
Buckley M, 1996, Ir J Med Sci, V165 Suppl 5, P1
[4]   SENSITIVE DETECTION OF HELICOBACTER-PYLORI BY USING POLYMERASE CHAIN-REACTION [J].
CLAYTON, CL ;
KLEANTHOUS, H ;
COATES, PJ ;
MORGAN, DD ;
TABAQCHALI, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (01) :192-200
[5]   Helicobacter pylori [J].
Dunn, BE ;
Cohen, H ;
Blaser, MJ .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (04) :720-+
[6]   Macrolide resistance in Helicobacter pylori: Mechanism and stability in strains from clarithromycin-treated patients [J].
Hulten, K ;
Gibreel, A ;
Skold, O ;
Engstrand, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) :2550-2553
[7]  
Maeda S, 2000, J CLIN MICROBIOL, V38, P210
[8]   Lack of a relationship between Lewis antigen expression and cagA, CagA, vacA and VacA status of Irish Helicobacter pylori isolates [J].
Marshall, DG ;
Hynes, SO ;
Coleman, DC ;
O'Morain, CA ;
Smyth, CJ ;
Moran, AP .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 1999, 24 (01) :79-90
[9]   Consensus guidelines:: Agreement and debate surrounding the optimal management of Helicobacter pylori infection [J].
McNamara, D ;
O'Morain, C ;
Facg, F .
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 14 (06) :511-517
[10]   Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial:: the MACH 2 study [J].
Mégraud, F ;
Lehn, N ;
Lind, T ;
Bayerdörffer, E ;
O'Morain, C ;
Spiller, R ;
Unge, P ;
Van Zanten, SV ;
Wrangstadh, M ;
Burman, CF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) :2747-2752